China Animal Husbandry waives rights in Zhongpu Biomedical stake transfer

China Animal Husbandry Industry Co., Ltd. (CAHIC) announced its decision to waive pre-emptive rights to acquire a 4.04% equity stake in Zhongpu Biomedical Pharmaceutical Co., Ltd. The stake, currently held by CITIC Agriculture Technology Co., Ltd., will be transferred to third parties at an assessed value of 17,514,236.28 yuan as of December 31, 2024. If Precone Biotechnology Co., Ltd., CAHIC's other major shareholder, exercises its right to subscribe, Zhongpu will cease to be a controlling subsidiary and will no longer be included in CAHIC's consolidated financial statements.

The equity transfer and related financial impact will be discussed at an extraordinary general meeting on December 1, 2025, held in Beijing and via an online voting system. This strategic decision aligns with CAHIC's business optimization goals and is not expected to significantly impact its current financial performance or operational results. An investor performance briefing will be held on November 26, 2025, to discuss third-quarter results and address investor queries.